We are live on ! Find out more
SRC

Shufro Rose & Co Portfolio holdings

AUM $1.47B
1-Year Est. Return 19.38%
This Fund
S&P 500
This Quarter Est. Return
+10.61%
1 Year Est. Return
+19.38%
3 Year Est. Return
+47.49%
5 Year Est. Return
+55.37%
10 Year Est. Return
+200.77%
AUM
$947M
AUM Growth
+$67.9M
Cap. Flow
-$19M
Cap. Flow %
-2.01%
Top 10 Hldgs %
31.65%
Holding
277
New
24
Increased
72
Reduced
85
Closed
14

Top Buys

Rank Stock Value
1
COL
Rockwell Collins
COL
+$10.4M
2
LTM
LIFE TIME FITNESS INC
LTM
+$10.1M
3
VMI icon
Valmont Industries
VMI
+$7.73M
4
DAR icon
Darling Ingredients
DAR
+$6.27M
5
PERY
Perry Ellis International Inc
PERY
+$1.66M

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$16.1M
2
EXC icon
Exelon
EXC
+$6.81M
3
CROX icon
Crocs
CROX
+$5.78M
4
TMO icon
Thermo Fisher Scientific
TMO
+$5.63M
5
AVY icon
Avery Dennison
AVY
+$5.52M

Sector Composition

Rank Sector Weight
1 Technology 21.01%
2 Industrials 17.97%
3 Healthcare 12.8%
4 Consumer Discretionary 12.43%
5 Energy 8.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SRGA
226
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$226K 0.02%
2,133
– –
AAME icon
227
Atlantic American Corp
AAME
$32.6M
$224K 0.02%
54,949
– –
QLGC
228
DELISTED
QLOGIC CORP
QLGC
$224K 0.02%
19,000
-400
-2% -$4.66K
ICCC icon
229
ImmuCell
ICCC
$102M
$221K 0.02%
51,863
– –
FAX
230
abrdn Asia-Pacific Income Fund
FAX
$595M
$220K 0.02%
6,367
– –
RCL icon
231
Royal Caribbean
RCL
$86.5B
$218K 0.02%
+4,600
New +$195K
NTRS icon
232
Northern Trust
NTRS
$22.2B
$216K 0.02%
+3,500
New +$201K
GDF
233
DELISTED
WESTERN ASSET GLB PARTNERS INCM FUND INC. COM
GDF
$213K 0.02%
19,700
– –
LPX icon
234
Louisiana-Pacific
LPX
$5.35B
$211K 0.02%
11,400
– –
LLY icon
235
Eli Lilly
LLY
$1.09T
$209K 0.02%
+4,102
New +$205K
DGICA icon
236
Donegal Group Class A
DGICA
$711M
$205K 0.02%
12,930
– –
FCT
237
First Trust Senior Floating Rate Income Fund II
FCT
$251M
$191K 0.02%
13,200
+1,500
+13% +$21.6K
MNP
238
DELISTED
Western Asset Municipal Partners Fund, Inc.
MNP
$188K 0.02%
13,709
– –
OXSQ icon
239
Oxford Square Capital
OXSQ
$147M
$170K 0.02%
16,500
– –
MHN
240
DELISTED
BlackRock MuniHoldings New Yrok Quality Fund
MHN
$164K 0.02%
13,200
– –
MPT
241
Medical Properties Trust
MPT
$2.89B
$163K 0.02%
+13,400
New +$171K
LGTY
242
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$158K 0.02%
16,050
– –
JQC icon
243
Nuveen Credit Strategies Income Fund
JQC
$702M
$148K 0.02%
15,300
– –
CCRD
244
DELISTED
CoreCard
CCRD
$143K 0.02%
88,273
– –
ALOT icon
245
AstroNova
ALOT
$224M
$134K 0.01%
10,004
– –
JHP
246
DELISTED
NUVEEN QUALITY PREFERRED INCOME FUND 3
JHP
$129K 0.01%
16,450
– –
LAKE icon
247
Lakeland Industries
LAKE
$106M
$121K 0.01%
23,100
-1,997
-8% -$10.6K
JTP
248
DELISTED
NUVEEN QUALITY PFD INCOME FD
JTP
$109K 0.01%
14,300
+1,800
+14% +$13.7K
NUV icon
249
Nuveen Municipal Value Fund
NUV
$1.91B
$108K 0.01%
+12,000
New +$107K
SPRT
250
DELISTED
support.com, Inc.
SPRT
$94K 0.01%
+8,333
New +$112K
8 9
10
11 12

Similar funds

SVWAG
Sound View Wealth Advisors Group Savannah, Georgia $1.47B AUM 18.47% 1-Year Est. Return
KRSITF
Kentucky Retirement Systems Insurance Trust Fund Frankfort, Kentucky $1.47B AUM 27.58% 1-Year Est. Return
CWM
Cahaba Wealth Management Atlanta, Georgia $1.47B AUM 13.36% 1-Year Est. Return
AAIM
American Assets Investment Management San Diego, California $1.47B AUM 43% 1-Year Est. Return
SWA
SFMG Wealth Advisors Plano, Texas $1.48B AUM 15.85% 1-Year Est. Return
VCP
Verus Capital Partners Scottsdale, Arizona $1.46B AUM 27.29% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return
ACM
Adelante Capital Management Alameda, California $1.46B AUM 8.98% 1-Year Est. Return

Shufro Rose & Co's Q4 2013 Portfolio in Review

As of Q4 2013, Shufro Rose & Co held 277 positions worth $947M, up 7.7% from $879M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Shufro Rose & Co's Q4 2013 filing shows 24 new, 72 increased, 85 reduced and 14 closed positions. Its largest new stake was Rockwell Collins: 145,705 shares worth $10.8M. The largest sale was Teva Pharmaceuticals, an estimated $16.1M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Industrials and Healthcare.

  • Shufro Rose & Co's largest Q4 2013 buy was Rockwell Collins: 145,705 shares worth $10.8M.
  • Shufro Rose & Co added most to Vishay Precision Group in Q4 2013, an estimated $1.63M increase.
  • Shufro Rose & Co's biggest Q4 2013 reduction was Teva Pharmaceuticals, cutting an estimated $16.1M.
  • Shufro Rose & Co fully exited MAIDENFORM BRANDS, INC in Q4 2013, selling an estimated $4.49M.
  • Shufro Rose & Co's ten largest holdings make up 32% of its $947M portfolio in Q4 2013.
  • Shufro Rose & Co opened 24 new positions and closed 14 in Q4 2013.
  • Shufro Rose & Co's portfolio value rose 7.7% quarter-over-quarter to $947M.

Based on Shufro Rose & Co's 13F filing for Q4 2013, filed 4 Feb 2014.